Rallybio Corp (RLYB) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rallybio Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • Rallybio Corp Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $2.09 M, a 31.4% decline year-over-year.
  • Rallybio Corp Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $9.96 M, a 5.02% decline year-over-year.
  • Rallybio Corp annual Share-based Payment Arrangement, Expense for 2023 was $10.9 M, a 15% increase from 2022.
  • Rallybio Corp annual Share-based Payment Arrangement, Expense for 2022 was $9.5 M, a 161% increase from 2021.
  • Rallybio Corp annual Share-based Payment Arrangement, Expense for 2021 was $3.65 M, a 418% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $9.96 M $2.09 M -$957 K -31.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.9 M $2.55 M +$255 K +11.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $10.7 M $2.63 M +$130 K +5.19% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $10.5 M $2.69 M +$45 K +1.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $10.5 M $3.05 M +$991 K +48.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $9.5 M $2.29 M +$765 K +50% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $8.73 M $2.5 M +$1.45 M +137% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $7.29 M $2.65 M +$2.11 M +391% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $5.18 M $2.05 M +$1.53 M +293% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $3.65 M $1.53 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $1.06 M +$780 K +284% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $539 K +$445 K +473% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $522 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $275 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $94 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.